United States v. Arnoldt
Opinion
Before
HITESMAN, GASTON, and MCCONNELL, Appellate Military Judges
UNITED STATES
Appellee
v.
Bailey C. ARNOLDT
Lance Corporal (E-3), U.S. Marine Corps Appellant
No. 201800372
Decided: 12 December 2019
Appeal from the United States Navy-Marine Corps Trial Judiciary. Military Judge: Colonel Matthew M. Kent, USMC (arraignment); Major Nathaniel Bonner, USMC (trial). Sentence adjudged 9 August 2018 by a special court- martial convened at Marine Corps Air Ground Combat Center, Twentynine Palms, California, consisting of officer and enlisted members. Sentence approved by the convening authority: reduction to E-1, forfeiture of two-thirds pay per month for 44 days, and a bad-conduct discharge.
For Appellant: Lieutenant Commander William Geraty, JAGC, USN
For Appellee: Lieutenant Joshua C. Fiveson, JAGC, USN; Lieutenant Kimberly Rios, JAGC, USN
This opinion does not serve as binding precedent, but may be cited as persuasive authority under NMCCA Rule of Appellate Procedure 30.2.
PER CURIAM:
Appellant was convicted, contrary to her pleas, of one specification of wrongful use of cocaine under Article 112a, Uniform Code of Military Justice (UCMJ), 10 U.S.C. § 912a (2012). The single issue presented is whether the evidence presented at trial is legally and factually sufficient to support Appellant’s conviction.
We hold that the evidence is not factually sufficient where the Government’s evidence relies solely upon the permissive inference associated with a positive urinalysis and the Urinalysis Program Coordinator (UPC) who testified at trial was not the UPC who supervised the collection and labeling of the tested specimen bottle.
I. BACKGROUND
On 9 March 2018, the Commanding Officer of Combat Logistics Battalion 7 (CLB-7) ordered a unit wide urinalysis sweep. Since the CLB-7’s regular UPC and urinalysis observers were subjects of the unit sweep, five UPCs and 15 urinalysis observers were borrowed from other units aboard Marine Corps Air Ground Combat Center Twentynine Palms.
The subject bottle containing the urine that tested positive for the cocaine metabolite was specimen (009) assigned with Batch #273 and corresponded to Appellant ’s Electronic Data Interchange Personal Identifier (EDIPI) number. At trial, the Government called Staff Sergeant RR who was the observer for the subject specimen . Staff Sergeant RR did not specifically remember Appellant, but testified as to her role as an observer during the urinalysis. In general, Staff Sergeant RR described what she does from the time she first begins supervising a subject Marine; through personal observation of the sample being provided; and culminating when she escorts the Marine back to the table where the UPC is located. In particular, she described the last step after leaving the head as follows: “I go back to the counter where the UPC is. The individual(s) set their sample down. The UPC will walk them through the rest of the process for labeling. At which point, I would locate this sheet [the “Testing Register” (Pros. Ex. 1)], sign them off, generally speaking . . . .” Staff Sergeant RR further testified that the Marine would sign the Testing Register (Pros. Ex. 1) sometime after she did. The evidence does not address whether she and the Marine signed the form contemporaneously, or whether the Marine executed the form sometime later under the supervision of the UPC.
The UPC who personally verified Appellant’s identity and was responsible for ensuring the correct labels were applied to the correct specimen bottles did not testi-
fy. 1 Instead, the Government presented testimony from another UPC, Gunnery Sergeant CS, who participated in the same unit sweep on 9 March 2018. Gunnery Sergeant CS described the procedures that he followed during the urinalysis, to include asking the servicemembers to verify “their label” and place their initials on it before he placed the label on the bottle. Gunnery Sergeant CS also described the steps he took to ensure that the servicemembers maintained control over their specimen bottle with a finger placed on top of it when they return from the head.
On cross-examination, Gunnery Sergeant CS acknowledged that the “Urinalysis Brief Sheet” (Pros. Ex. 2), which specified the responsibilities of both observers and coordinators, incorrectly listed him as the coordinator for the batch that included Appellant’s urine sample. Gunnery Sergeant CS further acknowledged that his initials were not on the label of Appellant’s urine bottle. Instead, the initials on the bottle were K.R.C., which corresponded to a different UPC who was in charge of verifying the Appellant’s identity and ensuring her specimen bottle was correctly labeled. Gunnery Sergeant CS confirmed on cross-examination, with respect to the subject bottle that “if that was a bottle from that particular testing, then, no, I did not touch the bottle or that label.” A member submitted a question to Gunnery Sergeant CS asking, “Is that bottle Lance Corporal Arnoldt’s exact bottle, or is it an example?” Gunnery Sergeant CS answered, “I couldn’t tell you without verifying the registry with the EDIPI, which is not visible on this bottle.”
The Urinalysis Brief Sheet (Pros. Ex. 2), states, “Urinalysis Coordinator / Observer responsibilities are set forth in MCO 5300.17 and [are] reemphasized below to ensure every urinalysis is handled with great care and positive control.” According to the exhibit, the UPC (not the observer) is responsible for verifying the identity of each individual. The document assigns six responsibilities to the observer, none of which involve verifying the identity of the individual to be tested or for ensuring that the correct label is applied to the correct urine specimen bottle.
Staff Sergeant JS was also called by the Government and testified that he was responsible for gathering and shipping the urine samples provided during the 9 March 2018 urinalysis to the Navy Drug Screening Laboratory (NDSL). Staff Sergeant JS confirmed that he signed the chain-of-custody form. NDSL received a sample from Batch 0273 with Appellant’s EDIPI number listed on the label. This sample also had initials on top of the bottle that matched Appellant’s name. No discrepancies were noted for the subject bottle.
Over objection, Dr. DQ, an expert from NDSL, testified and explained both the chain-of-custody and testing procedures used by the NDSL. In sum, Dr. DQ testified
1The UPC that did process the Appellant’s specimen bottle was on temporary duty at SERE school at the time of trial.
that the urine tested from the subject bottle tested positive for the metabolite of cocaine. The gas chromatography mass spectrometry (GCMS) test returned a result of 104 ng/ml for a metabolite of cocaine, which is above the Department of Defense cutoff level of 100 ng/ml.
Appellant presented two witnesses. First, Corporal DM, who had known Appellant for two-and-a-half years and did not socialize with her outside of work or on weekends, testified that he had not witnessed any manic, violent, or paranoid behavior by Appellant. He further testified that he had never seen Appellant possess cocaine or drug paraphernalia. The second witness, Lance Corporal AL, had only known Appellant for a month prior to the urinalysis (approximately 5 months by the time of trial) and did not socialize with her outside of the workplace. She testified that she had not witnessed any manic, violent, or paranoid behavior by Appellant. She also testified that although she was not really an expert, in her opinion the initials on the urinalysis bottle did not match Appellant’s handwriting, which she was familiar with from having worked in the same section.
The parties also stipulated to the jurisdictional requirements; the fact that cocaine is a Schedule II controlled substance; and the fact that the Appellant was married and the mother of a one-year-old daughter at the time of the alleged offense.
Free access — add to your briefcase to read the full text and ask questions with AI
United States v. Arnoldt (United States v. Arnoldt) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.